This Lululemon Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• Citigroup analyst Paul Lejuez downgraded the rating for Lululemon Athletica Inc. LULU from Buy to Neutral, while cutting the price target from $415 to $300. Lululemon shares settled at $272.06 on Wednesday. See how other analysts view this stock. See how other analysts view this stock.
• Argus Research analyst Kevin Heal downgraded Zions Bancorporation ZION from Buy to Hold. Zions Bancorp shares closed at $50.98 on Wednesday. See how other analysts view this stock.
• B of A Securities analyst Travis Steed downgraded the rating for Edwards Lifesciences Corporation EW from Buy to Neutral, while lowering the price target from $105 to $75. Edwards Lifesciences shares closed at $86.95 on Wednesday. See how other analysts view this stock.
• Stifel analyst Matthew Smith downgraded Lamb Weston Holdings, Inc. LW from Buy to Hold and slashed the price target from $115 to $60. Lamb Weston shares closed at $56.42 on Wednesday. See how other analysts view this stock.
• Needham analyst Quinn Bolton downgraded the rating for MaxLinear, Inc. MXL from Buy to Hold. MaxLinear shares closed at $22.29 on Wednesday. See how other analysts view this stock.

Check This Out:

• Wall Street’s Most Accurate Analysts Weigh In On 3 Energy Stocks With Over 6% Dividend Yields